Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 525 studies with search of: | "Cytarabine" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS
|
||||
2 | Recruiting |
Phase 3 Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)
|
||||
3 | Recruiting |
Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML
|
||||
4 | Recruiting |
Intrathecal DepoCyte and Lineage-Targeted Minimal Residual Disease-Oriented Therapy of Acute Lymphoblastic Leukemia
|
||||
5 | Recruiting |
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
|
||||
6 | Recruiting |
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
|
||||
7 | Not yet recruiting |
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
|
||||
8 | Recruiting |
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
|
||||
9 | Recruiting |
Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia
|
||||
10 | Suspended |
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
|
||||
11 | Recruiting |
Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
|
||||
12 | Recruiting |
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
|
||||
13 | Recruiting |
Safety and Tolerability Study of SNS-595 and Cytarabine Combination in Acute Myeloid Leukemia in Humans
|
||||
14 | Recruiting |
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory AML or High Risk MDS
|
||||
15 | Active, not recruiting |
Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
|
||||
16 | Completed |
Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients
|
||||
17 | Recruiting |
Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis
|
||||
18 | Recruiting |
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
|
||||
19 | Recruiting |
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
|
||||
20 | Recruiting |
Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin in CBF Leukemias
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |